Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 306

1.

Genetic Characterization of Rubella Virus Strains Detected in Spain, 1998-2014.

Martínez-Torres AO, Mosquera MM, De Ory F, González-Praetorius A, Echevarría JE.

PLoS One. 2016 Sep 13;11(9):e0162403. doi: 10.1371/journal.pone.0162403. eCollection 2016.

2.

[Epidemiology of measles in vaccinated people, Spain 2003-2014].

Risco-Risco C, Masa-Calles J, López-Perea N, Echevarría JE, Rodríguez-Caravaca G.

Enferm Infecc Microbiol Clin. 2016 Jun 1. pii: S0213-005X(16)30106-9. doi: 10.1016/j.eimc.2016.05.001. [Epub ahead of print] Spanish.

PMID:
27262819
3.

Detection of hepatitis C virus (HCV) core-specific antibody suggests occult HCV infection among blood donors.

Quiroga JA, Avellón A, Bartolomé J, Andréu M, Flores E, González MI, González R, Pérez S, Richart LA, Castillo I, Alcover J, Palacios R, Carreño V, Echevarría JM.

Transfusion. 2016 Jul;56(7):1883-90. doi: 10.1111/trf.13645. Epub 2016 May 17.

PMID:
27185049
4.

Evaluation of Chair-Side Assays in High Microbiological Caries-Risk Subjects.

Saravia ME, Silva LA, Silva RA, Lucisano MP, Echevarría AU, Echevarría JU, Nelson-Filho P.

Braz Dent J. 2015 Nov-Dec;26(6):592-5. doi: 10.1590/0103-6440201300389.

5.

Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS(®) system.

Seignères B, Descamps F, Croise R, Barlet V, Bouvier-Alias M, Chevaliez S, Pawlotsky JM, Abdelhady W, Rafik M, Avellon AM, Echevarria JM, Hausmann M, Dugua JM.

J Clin Virol. 2016 May;78:20-6. doi: 10.1016/j.jcv.2016.03.001. Epub 2016 Mar 4.

PMID:
26962723
6.

Full coding hepatitis E virus genotype 3 genome amplification method.

Muñoz-Chimeno M, Forero JE, Echevarría JM, Muñoz-Bellido JL, Vázquez-López L, Morago L, García-Galera MC, Avellón A.

J Virol Methods. 2016 Apr;230:18-23. doi: 10.1016/j.jviromet.2016.01.004. Epub 2016 Jan 16.

PMID:
26784284
7.

Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.

Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC Jr, Terashima A, Samalvides F, Pérez-Molina JA, Plana MN.

Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745. doi: 10.1002/14651858.CD007745.pub3. Review.

8.

Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial.

Gupta SK, McComsey GA, Lombaard J, Echevarría J, Orrell C, Avihingsanon A, Osiyemi O, Santoscoy M, Ray N, Stock DA, Joshi SR, Hanna GJ, Lataillade M.

Lancet HIV. 2016 Jan;3(1):e13-22. doi: 10.1016/S2352-3018(15)00231-3. Epub 2015 Dec 12.

PMID:
26762988
9.

Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.

Wolff M, Shepherd BE, Cortés C, Rebeiro P, Cesar C, Wagner Cardoso S, Pape JW, Padgett D, Sierra-Madero J, Echevarria J, McGowan CC; Caribbean, Central and South America Network for HIV Epidemiology.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):102-10. doi: 10.1097/QAI.0000000000000817.

PMID:
26761273
10.

Health assistance of displaced people along the Balkan route.

Escobio F, Echevarria J, Rubaki S, Viniczai V.

Lancet. 2015 Dec 19;386(10012):2475. doi: 10.1016/S0140-6736(15)01240-4. Epub 2015 Dec 18. No abstract available.

PMID:
26738711
11.

[Microbiological Surveillance of Measles and Rubella in Spain. Laboratory Network].

Echevarría JE, Fernández García A, de Ory F.

Rev Esp Salud Publica. 2015 Jul-Aug;89(4):381-91. doi: 10.4321/S1135-57272015000400006. Spanish.

12.

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial.

Lalezari JP, Latiff GH, Brinson C, Echevarría J, Treviño-Pérez S, Bogner JR, Thompson M, Fourie J, Sussmann Pena OA, Mendo Urbina FC, Martins M, Diaconescu IG, Stock DA, Joshi SR, Hanna GJ, Lataillade M; AI438011 study team.

Lancet HIV. 2015 Oct;2(10):e427-37. doi: 10.1016/S2352-3018(15)00177-0. Epub 2015 Sep 1.

PMID:
26423650
13.

Hepatitis E.

Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, Echevarría JM, Dalton H, Stramer SL.

Vox Sang. 2016 Jan;110(1):93-130. doi: 10.1111/vox.12285. Epub 2015 Jul 21. No abstract available.

PMID:
26198159
14.

Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.

Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarría JM.

J Med Virol. 2015 Nov;87(11):1934-9. doi: 10.1002/jmv.24251. Epub 2015 May 29.

PMID:
25959136
15.

Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.

Garrote H, de la Fuente A, Oña R, Rodríguez I, Echevarría JE, Sepúlveda JM, García JF.

Exp Hematol Oncol. 2015 Mar 1;4:8. doi: 10.1186/s40164-015-0003-4. eCollection 2015.

16.

Complete Genomic Sequence of European Bat Lyssavirus 1, Isolated from Eptesicus isabellinus in Spain.

Marston DA, Vázquez-Morón S, Ellis RJ, Wise EL, McElhinney LM, de Lamballerie X, Fooks AR, Echevarría JE.

Genome Announc. 2015 Feb 12;3(1). pii: e01518-14. doi: 10.1128/genomeA.01518-14.

17.

A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean.

Giganti MJ, Luz PM, Caro-Vega Y, Cesar C, Padgett D, Koenig S, Echevarria J, McGowan CC, Shepherd BE.

AIDS Res Hum Retroviruses. 2015 May;31(5):496-503. doi: 10.1089/AID.2014.0241. Epub 2015 Mar 6.

18.

Left ventricular pseudoaneurysm following thoracic aorta replacement.

Laguna G, Echevarría JR, Fernández M.

Rev Esp Cardiol (Engl Ed). 2015 Apr;68(4):340. doi: 10.1016/j.rec.2014.05.022. Epub 2014 Oct 30. No abstract available.

PMID:
25444378
19.

Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis.

Lalezari J, Latiff GH, Brinson C, Echevarria J, Treviño-Pérez S, Bogner JR, Stock D, Joshi SR, Hanna GJ, Lataillade M.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19530. doi: 10.7448/IAS.17.4.19530. eCollection 2014.

20.

HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis.

Brinson C, Lalezari J, Gulam LH, Thompson M, Echevarria J, Treviño-Pérez S, Stock D, Samit JR, George HJ, Lataillade M.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19529. doi: 10.7448/IAS.17.4.19529. eCollection 2014.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk